INOInovio Pharmaceuticals, Inc.

1.180USD-9.23%Mkt Cap: 122.01M $P/E:

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), c…

Key Statistics

Company
Market Cap122.01M $
Enterprise Value96.44M $
Revenue (TTM)0 $
Gross Profit-48.49M $
Net Income (TTM)-84.95M $
Revenue/Share0.0000 USD
Last Price1.180 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees112
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS45773H2013
Valuation
P/E (Trailing)
P/E (Forward)-2.75
PEG
EV/EBITDA-1.24
EV/Revenue
P/SInfinity
P/B13.91
EPS (TTM)-0.97
EPS (Forward)-0.44
52W Range
0.566625% of range2.980
52W High2.980 USD
52W Low0.5666 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-130000.00%
ROE-352.53%
ROA-114.31%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-88.63M $
CapEx (TTM)285.70K $
FCF Margin
FCF Yield-27.75%
Net Debt-28.67M $
Net Debt/EBITDA0.37
Balance Sheet
Debt/Equity0.39
Current Ratio1.00
Quick Ratio0.92
Book Value/Sh0.0870 USD
Cash/Share0.3550 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:12
Split DateJan 25, 2024
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.167 USD
Upside (mean)+168.4%
Target Range2.500 USD4.000 USD
$2.500+168.4% to mean$4.000
# Analysts3
Ownership
Shares Out.103.40M
Float96.22M
Insiders0.33%
Institutions46.01%
Short Interest
Short Ratio4.7d
Short % Float17.22%
Short % Out.15.53%
Shares Short16.04M
Short (prev mo.)15.04M
Technical
SMA 501.034 (+14.1%)
SMA 2001.476 (-20.1%)
Beta1.51
S&P 52W Chg18.16%
Avg Vol (30d)4.62M
Avg Vol (10d)6.13M
Technical Indicators
RSI (14)62.2
MACD0.0213
MACD Signal-0.0475
MACD Hist.+0.0688
BB Upper1.295 USD
BB Middle0.8815 USD
BB Lower0.4677 USD
BB Width93.88%
ATR (14)0.1011 USD
Vol Ratio (20d)0.81x